The anti-cancer effect of resveratrol nano-encapsulated supplements against breast cancer via the regulation of oxidative stress

References

• Aghaz, F., et al., 2021. Enhanced synergistic-antioxidant activity of melatonin and tretinoin by co-encapsulation into amphiphilic chitosan nanocarriers: during mice in vitro matured oocyte/morula-compact stage embryo culture model. Reproductive sciences, 28 (12), 3361–3379.
   PubMed Web of Science ®Google Scholar
• Annaji, M., et al., 2021. Resveratrol‐loaded nanomedicines for cancer applications. Cancer reports, 4 (3), e1353.
   Google Scholar
• Antoniraj, M.G., et al., 2022. Design and evaluation of redox responsive disulfide containing resveratrol loaded nanocarrier anti-cancer activity in the MDA-MB-231 cell line. Materials today communications, 32, 103873.
   Web of Science ®Google Scholar
• Athreya, K. and Xavier, M.F., 2017. Antioxidants in the treatment of cancer. Nutrition and cancer, 69 (8), 1099–1104.
   PubMed Web of Science ®Google Scholar
• Bhat, K.P., et al., 2001. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer research, 61 (20), 7456–7463.
   PubMed Web of Science ®Google Scholar
• Bohley, M., Haunberger, A., and Goepferich, A.M., 2019. Intracellular availability of poorly soluble drugs from lipid nanocapsules. European journal of pharmaceutics and biopharmaceutics, 139, 23–32.
   PubMed Web of Science ®Google Scholar
• Cao, Z. and Li, Y., 2004. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. European journal of pharmacology, 489 (1–2), 39–48.
   PubMed Web of Science ®Google Scholar
• Cassano, R., et al., 2020. Preparation, characterization and in vitro evaluation of resveratrol-loaded nanospheres potentially useful for human breast carcinoma. Journal of drug delivery science and technology, 57, 101748.
   Web of Science ®Google Scholar
• Chen, K., et al., 2020. A comparison study on the release kinetics and mechanism of bovine serum albumin and nanoencapsulated albumin from hydrogel networks. International journal of biological macromolecules, 163, 1291–1300.
   PubMed Web of Science ®Google Scholar
• Costa, P. and Lobo, J.M.S., 2001. Modeling and comparison of dissolution profiles. European journal of pharmaceutical sciences, 13 (2), 123–133.
   PubMed Web of Science ®Google Scholar
• Dai, X., et al., 2015. Breast cancer intrinsic subtype classification, clinical use and future trends. American journal of cancer research, 5 (10), 2929.
   PubMed Web of Science ®Google Scholar
• De Amicis, F., et al., 2011. Resveratrol, through NF‐Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB journal, 25 (10), 3695–3707.
   PubMed Web of Science ®Google Scholar
• De La Lastra, C.A. and Villegas, I., 2007. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochemical society transactions, 35 (Pt 5), 1156–1160.
   PubMed Web of Science ®Google Scholar
• Fan, C., et al., 2019. Resveratrol loaded oxidized mesoporous carbon nanoparticles: a promising tool to treat triple negative breast cancer. Biochemical and biophysical research communications, 519 (2), 378–384.
   PubMed Web of Science ®Google Scholar
• Fuchs-Tarlovsky, V., 2013. Role of antioxidants in cancer therapy. Nutrition, 29 (1), 15–21.
   PubMed Web of Science ®Google Scholar
• Fukui, M., Choi, H.J., and Zhu, B.T., 2010. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free radical biology & medicine, 49 (5), 800–813.
   PubMed Web of Science ®Google Scholar
• Gadag, S., et al., 2021. Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy. International journal of pharmaceutics, 606, 120877.
   PubMed Web of Science ®Google Scholar
• Ghanbari, E., Nejati, V., and Khazaei, M., 2016. Antioxidant and protective effects of Royal jelly on histopathological changes in testis of diabetic rats. International journal of reproductive BioMedicine, 14 (8), 519–526.
   PubMedGoogle Scholar
• Gianchecchi, E. and Fierabracci, A., 2020. Insights on the effects of resveratrol and some of its derivatives in cancer and autoimmunity: a molecule with a dual activity. Antioxidants, 9 (2), 91.
   Web of Science ®Google Scholar
• Herndl, G. J., Kaltenböck, E., and Müller-Niklas, G., 2018. Dialysis bag incubation as a nonradiolabeling technique to estimate bacterioplankton production in situ. In: Handbook of methods in aquatic microbial ecology, Boca Raton: CRC Press, 553–556.
   Google Scholar
• Hon, J.D.C., et al., 2016. Breast cancer molecular subtypes: from TNBC to QNBC. American journal of cancer research, 6 (9), 1864.
   PubMed Web of Science ®Google Scholar
• Huang, F., et al., 2014. Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells. Experimental and therapeutic medicine, 7 (6), 1611–1616.
   PubMed Web of Science ®Google Scholar
• Katouzian, I., et al., 2017. Formulation and application of a new generation of lipid nano-carriers for the food bioactive ingredients. Trends in food science & technology, 68, 14–25.
   Web of Science ®Google Scholar
• Kemp, J.A., et al., 2016. Combo nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Advanced drug delivery reviews, 98, 3–18.
   PubMed Web of Science ®Google Scholar
• Khazaei, M., et al., 2011. Sildenafil effect on nitric oxide secretion by normal human endometrial epithelial cells cultured in vitro. International journal of fertility & sterility, 5 (3), 142.
   PubMed Web of Science ®Google Scholar
• Kim, A., et al., 2021. Antioxidant nanomedicine significantly enhances the survival benefit of radiation cancer therapy by mitigating oxidative stress‐induced side effects. Small, 17 (21), 2008210.
   Web of Science ®Google Scholar
• Liu, Z., et al., 2019. Resveratrol induces p53 in colorectal cancer through SET7/9. Oncology letters, 17 (4), 3783–3789.
   PubMed Web of Science ®Google Scholar
• Livak, K.J. and Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods, 25 (4), 402–408.
   PubMed Web of Science ®Google Scholar
• Lubbers, J., et al., 2011. Resveratrol enhances anti-proliferative effect of VACM-1/cul5 in T47D cancer cells. Cell biology and toxicology, 27 (2), 95–105.
   PubMed Web of Science ®Google Scholar
• Mei, T., et al., 2020. Fibrinolytic tissue plasminogen activator installed redox-active nanoparticles (t-PA@ iRNP) for cancer therapy. Biomaterials, 259, 120290.
   PubMed Web of Science ®Google Scholar
• Melo, B.L., et al., 2022. Chitosan-based injectable in situ forming hydrogels containing dopamine-reduced graphene oxide and resveratrol for breast cancer chemo-photothermal therapy. Biochemical engineering journal, 185, 108529.
   Web of Science ®Google Scholar
• Mirzapur, P., et al., 2018. Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes. Life sciences, 205, 45–53.
   PubMed Web of Science ®Google Scholar
• Mondal, A. and Bennett, L.L., 2016. Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage. Biomedicine & pharmacotherapy, 84, 1906–1914.
   PubMed Web of Science ®Google Scholar
• Motiei, M. and Kashanian, S., 2017. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs. European journal of pharmaceutical sciences, 99, 285–291.
   PubMed Web of Science ®Google Scholar
• Pradhan, R., et al., 2021. Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages. The journal of nutritional biochemistry, 92, 108624.
   PubMed Web of Science ®Google Scholar
• Qin, L., et al., 2020. Preparation, characterization, and in vitro evaluation of resveratrol-loaded cellulose aerogel. Materials, 13 (7), 1624.
   PubMed Web of Science ®Google Scholar
• Rauf, A., et al., 2018. Resveratrol as an anti-cancer agent: a review. Critical reviews in food science and nutrition, 58 (9), 1428–1447.
   PubMed Web of Science ®Google Scholar
• Rubiolo, J.A., Mithieux, G., and Vega, F.V., 2008. Resveratrol protects primary rat hepatocytes against oxidative stress damage: Activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. European journal of pharmacology, 591 (1–3), 66–72.
   PubMed Web of Science ®Google Scholar
• Santandreu, F.M., et al., 2011. Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells. Cellular physiology and biochemistry, 28 (2), 219–228.
   PubMedGoogle Scholar
• Siddiqui, I.A., et al., 2015. Resveratrol nanoformulation for cancer prevention and therapy. Annals of the New York academy of sciences, 1348 (1), 20–31.
   PubMed Web of Science ®Google Scholar
• Singh, N., et al., 2011. Resveratrol as an adjunct therapy in cyclophosphamide‐treated MCF‐7 cells and breast tumor explants. Cancer science, 102 (5), 1059–1067.
   PubMed Web of Science ®Google Scholar
• Sunkireddy, P., et al., 2013. Natural antioxidant biomolecules promises future nanomedicine based therapy for cataract. Colloids and surfaces B biointerfaces, 112, 554–562.
   PubMed Web of Science ®Google Scholar
• Vasconcelos, T., et al., 2019. Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile. European journal of pharmaceutical sciences, 137, 105011.
   PubMed Web of Science ®Google Scholar
• Vijayakumar, M.R., et al., 2016. Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of Vitamin E TPGS coated trans resveratrol liposomes. Colloids and surfaces B biointerfaces, 145, 479–491.
   PubMed Web of Science ®Google Scholar
• Wang, D., Gao, Z., and Zhang, X., 2018. Resveratrol induces apoptosis in murine prostate cancer cells via hypoxia-inducible factor 1-alpha (HIF-1α)/reactive oxygen species (ROS)/P53 signaling. Medical science monitor, 24, 8970–8976.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2017. In vitro and in vivo evaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions. Colloids and surfaces B biointerfaces, 160, 462–472.
   PubMed Web of Science ®Google Scholar
• Wang, X., Wang, D., and Zhao, Y., 2015. Effect and mechanism of resveratrol on the apoptosis of lung adenocarcinoma cell line A549. Cell biochemistry and biophysics, 73 (2), 527–531.
   PubMed Web of Science ®Google Scholar
• Wilkinson, L. and Gathani, T., 2022. Understanding breast cancer as a global health concern. The British journal of radiology, 95 (1130), 20211033.
   PubMed Web of Science ®Google Scholar
• Yasueda, A., Urushima, H., and Ito, T., 2016. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review. Integrative cancer therapies, 15 (1), 17–39.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2022. Co-delivery of docetaxel and resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer. European journal of pharmaceutical sciences, 174, 106199.
   PubMed Web of Science ®Google Scholar
• Zhang, S., et al., 2004. Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells. British journal of cancer, 91 (1), 178–185.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., et al., 2020. Anti-breast cancer activity of resveratrol encapsulated in liposomes. Journal of materials chemistry B, 8 (1), 27–37.
   PubMed Web of Science ®Google Scholar